Fresenius Medical Care stock slips to EUR 39.53, down 0.45%
Published on 11/18/2026 at 08:12 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSShareholder structure and buyback remain in focus
- Fresenius said on November 12 that its sale of 13.4 million Fresenius Medical Care shares would reduce its holding to about 20 percent and raise approximately EUR 524 million.
- Fresenius Medical Care reported on November 16 that it bought back 500 shares between November 9 and November 13, bringing first-tranche purchases to 11,252,537 shares.
- The company provides dialysis treatment and kidney-care products worldwide.
Fresenius Medical Care stock traded at 39.53 euros on Lang & Schwarz at 08:10 CET on Wednesday, November 18, 2026, 0.45 percent below the Xetra close of Tuesday, November 17, at 39.71 euros.
Stake sale reshapes shareholder structure
On November 12, Fresenius said it had sold 13.4 million Fresenius Medical Care shares at EUR 39.00 each, generating gross proceeds of approximately EUR 524 million. The transaction was expected to settle on November 16 and would reduce Fresenius's holding to approximately 20 percent of issued share capital. The announcement was published by the Financial Times from an EQS release.
Fresenius Medical Care also reported on November 16 that it bought back 500 shares between November 9 and November 13. The first tranche of its buyback had reached 11,252,537 shares.
The company provides dialysis treatment and kidney-care products worldwide. Its shares are listed in Germany and trade on Xetra under the symbol FME.
German equities are tracked in the DAX.
